The surprisingly diverse functions of IL-17 have made it among the more favourable immunotherapeutic target candidates for the treatment of a wide range of diseases, including cancers [17], autoimmune diseases [18] and infectious diseases [19]. This evidence concerns the gene IL17A and cancer.